4.5 Article

Resveratrol mitigates lipopolysaccharide- and Aß-mediated microglial inflammation by inhibiting the TLR4/NF-?B/STAT signaling cascade

Journal

JOURNAL OF NEUROCHEMISTRY
Volume 120, Issue 3, Pages 461-472

Publisher

WILEY
DOI: 10.1111/j.1471-4159.2011.07594.x

Keywords

A ss; Alzheimer's disease; microglia; NF-?B; resveratrol; TLR4

Funding

  1. National Institutes of Health [PO1 AT004511]

Ask authors/readers for more resources

Activation of microglia, the resident macrophages of the brain, around the amyloid plaques is a key hallmark of Alzheimers disease (AD). Recent evidence in mouse models indicates that microglia are required for the neurodegenerative process of AD. Amyloid-beta (A beta) peptides, the core components of the amyloid plaques, can trigger microglial activation by interacting with several Toll-like receptors (TLRs), including TLR4. In this study, we show that resveratrol, a natural polyphenol associated with anti-inflammatory effects and currently in clinical trials for AD, prevented the activation of murine RAW 264.7 macrophages and microglial BV-2 cells treated with the TLR4 ligand, lipopolysaccharide (LPS). Resveratrol preferentially inhibited nuclear factor ?-light-chain-enhancer of activated B cells (NF-?B) activation upon LPS stimulation by interfering with IKK and I?B phosphorylation, an effect that potently reduced the transcriptional stimulation of several NF-?B target genes, including tumor necrosis factor-a and interleukin-6. Consequently, downstream phosphorylation of signal transducer and activator of transcription (STAT)1 and STAT3 upon LPS stimulation was also inhibited by resveratrol. We found that resveratrol acted upstream in the activation cascade by interfering with TLR4 oligomerization upon receptor stimulation. Resveratrol treatment also prevented the pro-inflammatory effect of fibrillar A beta on macrophages by potently inhibiting the effect of A beta on I?B phosphorylation, activation of STAT1 and STAT3, and on tumor necrosis factor-a and interleukin-6 secretion. Importantly, orally administered resveratrol in a mouse model of cerebral amyloid deposition lowered microglial activation associated with cortical amyloid plaque formation. Together this work provides strong evidence that resveratrol has in vitro and in vivo anti-inflammatory effects against A beta-triggered microglial activation. Further studies in cell culture systems showed that resveratrol acted via a mechanism involving the TLR4/NF-?B/STAT signaling cascade.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available